Journal of the American Chemical Society · 2005 · 68 citations · 13 references
Life SciencesMedicinal ChemistryPharmacologyChromatin BiologyEpigeneticsGene ExpressionChromatinEnzyme InhibitionHistone ModificationsHistone Post-translational ModificationsCoenzyme SpecificityDisulfide ChemistryDisulfide LinkersHistone AcetylationHistone Acetyltransferase InhibitionHistone AcetyltransferasesHistone-lysine Acetylation
This paper describes the first potent and selective p300 histone acetyltransferase (HAT) inhibitor which is effective in live cells. This compound 7 is a coenzyme A analogue conjugated to a cell permeabilizing oligoArg peptide via disulfide linkage. This compound was shown to block cellular histone acetylation and transcription using a p300-sensitive reporter. It should thus be broadly useful for dissecting the role of p300 HAT activity in physiologic and disease states.
13
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Vasily Ogryzko, R. Louis Schiltz, Valya Russanova et al. · Cell · 1996 · 3K citations · Full text
The CBP co-activator is a histone acetyltransferase
Andrew J. Bannister, Tony Kouzarides · Nature · 1996 · 1.8K citations
Karanam Balasubramanyam, Radhika A. Varier, Mohammad Altaf et al. · Journal of Biological Chemistry · 2004 · 819 citations · Full text
Regulation of the p300 HAT domain via a novel activation loop
Dongxia Wang, Ling Wang, Marcella Fulco et al. · Nature Structural & Molecular Biology · 2004 · 423 citations